A non-government resource built from CMS public data
denosumab biosimilars on SilverScript Choice (S5601-010)
Jubbonti, Ospomyv and others
Covered.
TierTier. The cost level the plan puts a drug on. Lower tiers usually cost the patient less. 4 (non-preferred drug). Quantity limit of 1 per 180 days.
$57.06
Patient pays / month, after deductible
$172.90
Patient pays / month, before the $615.00 deductible
$171.17
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket capOut-of-pocket cap. Once the patient has paid this much in a year for covered Part D drugs, they pay nothing more for the rest of that year.
OSPOMYV 60 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $172.90 for a month.
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details